Histone H2B as a functionally important plasminogen receptor on macrophages.
Plasminogen (Plg) facilitates inflammatory cell recruitment, a function that depends upon its binding to Plg receptors (Plg-Rs). However, the Plg-Rs that are critical for cell migration are not well defined. Three previously characterized Plg-Rs (alpha-enolase, annexin 2, and p11) and a recently identified Plg-R (histone H2B [H2B]) were assessed for their contribution to Plg binding and function on macrophages. Two murine macrophage cell lines (RAW 264.7 and J774A.1) and mouse peritoneal macrophages induced by thioglycollate were analyzed. All 4 Plg-Rs were present on the surface of these cells and showed enhanced expression on the thioglycollate-induced macrophages compared with peripheral blood monocytes. Using blocking Fab fragments to each Plg-R, H2B supported approximately 50% of the Plg binding capacity, whereas the other Plg-Rs contributed less than 25%. Anti-H2B Fab also demonstrated a major role of this Plg-R in plasmin generation and matrix invasion. When mice were treated intravenously with anti-H2B Fab, peritoneal macrophage recruitment in response to thioglycollate was reduced by approximately 45% at 24, 48, and 72 hours, with no effect on blood monocyte levels. Taken together, these data suggest that multiple Plg-Rs do contribute to Plg binding to macrophages, and among these, H2B plays a very prominent and functionally important role.
Das
Riku
R
Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Department of Molecular Cardiology, Cleveland Clinic, OH, USA.
Burke
Tim
T
Plow
Edward F
EF
D000818:Animals; D000954:Antigens, Surface / Q000378:metabolism; D002460:Cell Line; D006657:Histones / Q000378:metabolism / Q000502:physiology*; D007249:Inflammation / Q000209:etiology; D008264:Macrophages / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D009000:Monocytes / Q000378:metabolism; D010958:Plasminogen / Q000378:metabolism; D011485:Protein Binding; D011956:Receptors, Cell Surface / Q000378:metabolism / Q000502:physiology*; D055293:Receptors, Urokinase Plasminogen Activator
D000954:Antigens, Surface; D006657:Histones; C524899:Plaur protein, mouse; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D010958:Plasminogen
Thromb Haemost. 1999 Sep;82 Suppl 1:4-7
10695477
Methods. 2000 Jun;21(2):103-10
10816371
Blood. 2001 Feb 1;97(3):777-84
11157497
Blood. 2001 Feb 15;97(4):1070-8
11159539
J Biol Chem. 2001 Jun 1;276(22):19078-83
11264290
J Hepatol. 2001 Dec;35(6):781-9
11738106
J Biol Chem. 2002 Sep 13;277(37):33564-70
12087108
J Clin Invest. 2002 Nov;110(9):1275-82
12417566
Am J Hematol. 2003 Apr;72(4):234-42
12666133
J Biol Chem. 2003 Jul 11;278(28):25577-84
12730231
J Thromb Haemost. 2003 Aug;1(8):1683-7
12911578
Thromb Haemost. 2003 Oct;90(4):724-33
14515195
Blood. 2003 Oct 15;102(8):2819-27
12829586
Curr Drug Targets Inflamm Allergy. 2003 Sep;2(3):257-65
14561160
J Immunol. 2004 Apr 1;172(7):4410-7
15034056
J Biol Chem. 2004 Apr 23;279(17):18063-72
14769799
J Thromb Haemost. 2004 Oct;2(10):1798-805
15456492
J Pathol Bacteriol. 1966 Apr;91(2):575-87
5950612
Cancer Res. 1982 Apr;42(4):1530-6
6949641
J Clin Invest. 1985 Sep;76(3):991-8
3876357
J Cell Biol. 1986 Dec;103(6 Pt 1):2411-20
3023400
Cell Immunol. 1989 Jan;118(1):178-91
2910501
J Cell Biol. 1990 Oct;111(4):1673-83
2170426
Biochemistry. 1991 Feb 12;30(6):1682-91
1847072
J Biol Chem. 1991 Jul 5;266(19):12329-36
1712017
J Biol Chem. 1991 Jul 5;266(19):12752-8
1829461
Arch Biochem Biophys. 1991 May 1;286(2):625-8
1654795
Blood. 1991 Nov 1;78(9):2318-27
1932747
J Leukoc Biol. 1994 Mar;55(3):410-22
7509844
J Biol Chem. 1994 Aug 19;269(33):21191-7
8063740
J Biol Chem. 1994 Aug 19;269(33):21198-203
8063741
J Neurochem. 1994 Dec;63(6):2048-57
7964722
Thromb Res. 1994 Aug 15;75(4):371-81
7997975
Eur J Biochem. 1995 Jan 15;227(1-2):407-15
7851415
Am J Clin Pathol. 1995 Apr;103(4):466-71
7726145
FASEB J. 1995 Jul;9(10):939-45
7615163
Biochem Pharmacol. 1995 Jul 31;50(3):299-309
7646532
N Engl J Med. 2005 Apr 21;352(16):1685-95
15843671
Br J Haematol. 2005 Nov;131(4):553-4; author reply 554-6
16281949
Biochemistry. 2006 Aug 8;45(31):9463-74
16878981
J Clin Invest. 1995 Nov;96(5):2534-8
7593646
Thromb Haemost. 1995 Jul;74(1):294-301
8578475
J Clin Invest. 1997 Jan 15;99(2):200-8
9005988
Blood. 1997 Jun 15;89(12):4574-83
9192782
Circ Res. 1997 Nov;81(5):829-39
9351457
Blood. 1998 Mar 15;91(6):2005-9
9490683
Br J Cancer. 1998 May;77(10):1586-97
9635833
J Clin Invest. 1998 Jul 15;102(2):283-93
9664069
J Exp Med. 1998 Sep 21;188(6):1029-37
9743521
J Clin Invest. 1998 Nov 15;102(10):1788-97
9819364
Blood. 1999 Jun 1;93(11):3839-46
10339491
Exp Cell Res. 2005 Feb 1;303(1):22-31
15572024
J Biol Chem. 2005 Jan 14;280(2):1336-45
15485828
Curr Pharm Des. 2005;11(5):569-80
15720276